Figure 4 Valve-in-valve implantations in degenerated surgical valves

Slides:



Advertisements
Similar presentations
CoreValve ® System Procedural Best Practices for: May 2013 CoreValve ® to Stented Bioprostheses Valve-in-Valve These best practices were created with detailed.
Advertisements

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Transcatheter Valve-in-Valve and Valve-in-Ring for.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Transcatheter Aortic Valve-in-Valve Implantation for Patients With Degenerative Surgical Bioprosthetic Valves  Danny Dvir, MD, Marco Barbanti, MD, John.
Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet Thrombosis  Koohyar Vahidkhah, PhD, Shahnaz Javani, MS, Mostafa.
Nat. Rev. Cardiol. doi: /nrcardio
Transapical Off-Pump Valve-in-Valve Implantation in Patients With Degenerated Aortic Xenografts  Jörg Kempfert, MD, Arnaud Van Linden, MD, Axel Linke,
Nat. Rev. Cardiol. doi: /nrcardio
A: Edwards Sapien percutaneous aortic valve (Reproduced with permission from Edwards Lifesciences, Irvine, California.) B: Medtronic CoreValve, currently.
Figure 3: Mean gradient according to valve size, 6 weeks after surgery
Long-term durability of Edwards bioprosthetic aortic valves
Valvular Heart Disease: Classic Teaching and Emerging Paradigms
Nat. Rev. Cardiol. doi: /nrcardio
Figure 10 Assessment of myocardial fibrosis
Figure 5 TAVI with a self-expanding valve in
Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 BMI and cardiorespiratory fitness levels
Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition
Figure 3 3D printing of aortic and mitral valves
Figure 8 4D magnetic resonance imaging patterns
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Health-care system today
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Cardiovascular risk and disease across the life-course
Transatlantic editorial on transcatheter aortic valve replacement
Figure 4 TAVI for bicuspid aortic valve disease
Figure 1 Types of surgical and transcatheter aortic valves
Transapical transcatheter aortic valve-in-valve implantation: Clinical and hemodynamic outcomes beyond 2 years  Jian Ye, MD, FRCSC, John G. Webb, MD,
Figure 3 Neural crest cell migration
Figure 2 Global cost of HF per capita in 2012
Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.
Figure 2 A patient with aortic stenosis and mitral regurgitation
Transapical transcatheter aortic valve implantation and off-pump left internal thoracic artery–left anterior descending anastomosis: Back to the future? 
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Transapical Aortic Valve Implantation: Therapy of Choice for Patients With Aortic Stenosis and Porcelain Aorta?  Jörg Kempfert, MD, Arnaud Van Linden,
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Cardiol. doi: /nrcardio
A.A. Klein, S.T. Webb, S. Tsui, C. Sudarshan, L. Shapiro, C. Densem 
Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Bioresorbable vascular scaffold apposition and strut coverage
Nat. Rev. Cardiol. doi: /nrcardio
Figure 12 Cardiac gossypiboma
Figure 6 The neurogenic components of angina
Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients.
Moritz Seiffert et al. JCIN 2012;5:
Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet Thrombosis  Koohyar Vahidkhah, PhD, Shahnaz Javani, MS, Mostafa.
Simultaneous transapical transcatheter aortic and mitral valve replacement in a high-risk patient with a previous mitral bioprosthesis  Adil H. Al Kindi,
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Jamil Aboulhosn et al. JCIN 2017;10:53-63
Deterministic univariate sensitivity analyses (BAV, balloon aortic valvuloplasty; ICU, intensive care unit; MM, medical management; QALY, quality-adjusted.
Ronald K. Binder et al. JCIN 2013;6:
Transcatheter aortic valve implantation: The European experience
Aortic Valve Replacement After Transapical Valve-in-Valve Implantation
Nat. Rev. Cardiol. doi: /nrcardio
Presentation transcript:

Figure 4 Valve-in-valve implantations in degenerated surgical valves Figure 4 | Valve-in-valve implantations in degenerated surgical valves. From left to right, the images show the orthogonal view before balloon valvuloplasty, valve positioning, and the final angiographic result. a | Edwards SAPIEN® 23 (Edwards Lifesciences Corporation, USA) in a Carpentier–Edwards PERIMOUNT® 21 (Edwards Lifesciences Corporation, USA). b | Edwards SAPIEN® 26 in a Medtronic Hancock® 25 (Medtronic CV Luxembourg S.a.r.l., Luxembourg). c | Edwards SAPIEN® 23 in a Sorin Mitroflow® 23 (Sorin Group, Canada). Reprinted from Kempfert, J. et al. Transapical off-pump valve-in-valve implantation in patients with degenerated aortic xenografts. Ann. Thorac. Surg. 89 (6), 1934–1941 © (2010), with permission from Elsevier. Reprinted from Kempfert, J. et al. Transapical off-pump valve‑in‑valve implantation in patients with degenerated aortic xenografts. Ann. Thorac. Surg. 89 (6), 1934–1941 © (2010), with permission from Elsevier Arsalan, M. & Walther, T. (2016) Durability of prostheses for transcatheter aortic valve implantation Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.43